CD4 and systemic lupus erythematosus: In a mouse model of systemic lupus erythematosus, a systemic autoimmune disorder, long-term administration of CTLA4Ig significantly decreased CD4+ T cell numbers and reduced the population of auto-reactive B cells producing anti-DNA antibodies [39].